Category: CovidienSyndicate content

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Medtronic issues an update on the debt financing behind its pending $43 billion acquisition of Covidien.

Medtronic updates on $43B Covidien deal financing

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pushing the envelope

October 24, 2014 by Brian Johnson

In this DeviceTalks preview, we catch up with Masimo CEO Joe Kiani to discuss new challenges facing the company and how medtech can break the cycle of the era of 'good-enough' innovation.

Masimo's Kiani on 'good-enough innovation,' Medtronic, Apple and 25 years of pushing the envelope

Survey: Stroke still a mystery to many

October 23, 2014 by Alexander Soule

Despite stroke being the 2nd leading cause of death worldwide, many people still don't recognize risk factors and warning signs, according to a new poll sponsored by Covidien and the World Stroke Organization.

Survey: stroke still mystery to many

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien, Medtronic shares jump on affirmation of $43B merger

October 22, 2014 by Brad Perriello

Shares of Medtronic and Covidien gain after Medtronic affirms its $43 billion acquisition plans, saying it now expects to close the deal for Covidien late this year or early in 2015.

Covidien, Medtronic shares jump on affirmation of $43B merger

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

JNJ/Synthes integration continues to bring hefty charges | The week in medtech M&A

October 22, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: JNJ continues to pay hefty integration charges on Synthes deal; Stryker: Mako sales not as strong as we hoped; ConvaTec owners appoint banks to explore sale: sources; BD buys Irish next-gen sequencing startup GenCell Biosystems; Valeant says may raise Allergan bid; beats on profit

JNJ continues to pay hefty integration charges on Synthes deal

October 16, 2014 by Brian Johnson

Covidien wins injunction against J&J unit's surgical shears

October 17, 2014 by Brad Perriello

A federal judge bars sales of Johnson & Johnson unit Ethicon Endo-Surgery's Harmonic Ace +7 surgical shears in a patent infringement lawsuit brought by Covidien.

Covidien wins injunction against J&J unit's surgical shears

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

JNJ continues to pay hefty integration charges on Synthes deal

October 16, 2014 by Brian Johnson

More than 2½ years after it spent $21.3 billion on Synthes, Johnson & Johnson continues to take hefty charges on integrating the orthopedics company into its DePuy franchise.

JNJ continues to pay hefty integration charges on Synthes deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp